DESAFIOS NO MANEJO DE ANEMIA FERROPRIVA GRAVE EM PACIENTES IDOSOS: RELATO DE CASO Article Swipe
DB Menin
,
MF Barros
,
RAT Takaes
,
GE Dresch
,
IP Roman
,
Les P. Miranda
,
MC Capelin
,
RA Sri Martini
,
V. C. Araujo
,
MAF Chaves
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1016/j.htct.2024.09.014
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1016/j.htct.2024.09.014
Introdução/Objetivo: A anemia ferropriva causada pela deficiência de ferro, é a carência nutricional mais prevalente na saúde pública. Essa doença atinge todas as classes sociais, com maior evidência em crianças e mulheres, podendo atingir implicações graves. O objetivo deste trabalho é relatar o caso de uma paciente com anemia crônica causada pela deficiência de ferro. Materiais e métodos: Estudo realizado por meio de coleta de dados do prontuário hospitalar da paciente. Relato de caso: Paciente E.F.S., sexo feminino, 61 anos, apresenta anemia crônica desde 2010, fazendo transfusões frequentes. A mesma deu entrada no hospital apresentando hemoglobina de 3,1 g/dL, ferritina 4,5 ng/mL e ferro sérico 31 ug/dL. Resultados/Discussão: Para investigar o caso da paciente, solicitou-se exames de rastreio de anemia e avaliação hematológica. Devido a hemoglobina baixa, a mesma recebeu transfusão de 2CH e reposição de ferro. Após a transfusão sanguínea, a hemoglobina aumentou para 5,3 g/dL. Ao decorrer do tratamento a paciente recebeu mais uma transfusão e permaneceu com a reposição de ferro, logo apresentou-se estável hemodinamicamente e com melhora dos sintomas, apresentando a hemoglobina com valor de 6,1 g/dL. Em avaliação hematológica, devido aos riscos de mais transfusões, optou-se em manter o tratamento com reposição de ferro endovenoso na UBS de origem e retornar ao ambulatório em duas semanas para avaliar novo perfil de ferro. Porém, a paciente voltou ao acompanhamento ambulatorial após 30 dias, tendo o resultado de hemoglobina 7,1 g/dL, ferro sérico 16,0 ug/dL, ferritina 15,9 ng/mL e capacidade de ligação de ferro 364,0 ug/dL. A concentração de hemoglobina considerada normal para mulheres é de 12 g/dL. Quanto aos valores de referência para ferro sérico, considera-se dentro dos níveis aceitáveis os valores de 37 a 170 ug/dL e para ferritina 4,6 a 204,0 ng/dL. Considerando o quadro da paciente, pode-se classificá-lo como anemia grave, pois a hemoglobina apresenta-se < 7 g/dL, consequentemente nesses casos indica-se a transfusão sanguínea. Entretanto, a transfusão ameniza o problema temporariamente, porém não corrige a anemia, a qual deve ser investigada a causa que está levando a deficiência de ferro, e investigar um possível sangramento crônico, para enfim tratar definitivamente a Anemia Ferropriva. Portanto, após estabelecer o paciente com a transfusão, deve-se continuar a reposição de ferro e acompanhar a evolução. Conclusão: Levando em consideração o relato de caso, percebe-se que houve melhora nos resultados finais da paciente, porém ainda não estão dentro dos valores de referências. Avaliando os relatos iniciais e a idade da paciente, nota-se que o caso clínico necessita de uma investigação mais criteriosa para obter resultados positivos com o tratamento.
Related Topics
Metadata
- Type
- article
- Language
- pt
- Landing Page
- https://doi.org/10.1016/j.htct.2024.09.014
- OA Status
- diamond
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4403569652
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4403569652Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1016/j.htct.2024.09.014Digital Object Identifier
- Title
-
DESAFIOS NO MANEJO DE ANEMIA FERROPRIVA GRAVE EM PACIENTES IDOSOS: RELATO DE CASOWork title
- Type
-
articleOpenAlex work type
- Language
-
ptPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-10-01Full publication date if available
- Authors
-
DB Menin, MF Barros, RAT Takaes, GE Dresch, IP Roman, Les P. Miranda, MC Capelin, RA Sri Martini, V. C. Araujo, MAF ChavesList of authors in order
- Landing page
-
https://doi.org/10.1016/j.htct.2024.09.014Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
diamondOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1016/j.htct.2024.09.014Direct OA link when available
- Concepts
-
Medicine, Anemia, Humanities, Gynecology, Internal medicine, PhilosophyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4403569652 |
|---|---|
| doi | https://doi.org/10.1016/j.htct.2024.09.014 |
| ids.doi | https://doi.org/10.1016/j.htct.2024.09.014 |
| ids.openalex | https://openalex.org/W4403569652 |
| fwci | 0.0 |
| type | article |
| title | DESAFIOS NO MANEJO DE ANEMIA FERROPRIVA GRAVE EM PACIENTES IDOSOS: RELATO DE CASO |
| biblio.issue | |
| biblio.volume | 46 |
| biblio.last_page | S8 |
| biblio.first_page | S8 |
| topics[0].id | https://openalex.org/T10554 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9580000042915344 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2716 |
| topics[0].subfield.display_name | Genetics |
| topics[0].display_name | Hemoglobinopathies and Related Disorders |
| topics[1].id | https://openalex.org/T10452 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9332000017166138 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2720 |
| topics[1].subfield.display_name | Hematology |
| topics[1].display_name | Iron Metabolism and Disorders |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.9697165489196777 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2778248108 |
| concepts[1].level | 2 |
| concepts[1].score | 0.5759029388427734 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q5445 |
| concepts[1].display_name | Anemia |
| concepts[2].id | https://openalex.org/C15708023 |
| concepts[2].level | 1 |
| concepts[2].score | 0.481052428483963 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q80083 |
| concepts[2].display_name | Humanities |
| concepts[3].id | https://openalex.org/C29456083 |
| concepts[3].level | 1 |
| concepts[3].score | 0.3322575092315674 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q1221899 |
| concepts[3].display_name | Gynecology |
| concepts[4].id | https://openalex.org/C126322002 |
| concepts[4].level | 1 |
| concepts[4].score | 0.0712604820728302 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[4].display_name | Internal medicine |
| concepts[5].id | https://openalex.org/C138885662 |
| concepts[5].level | 0 |
| concepts[5].score | 0.0 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q5891 |
| concepts[5].display_name | Philosophy |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.9697165489196777 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/anemia |
| keywords[1].score | 0.5759029388427734 |
| keywords[1].display_name | Anemia |
| keywords[2].id | https://openalex.org/keywords/humanities |
| keywords[2].score | 0.481052428483963 |
| keywords[2].display_name | Humanities |
| keywords[3].id | https://openalex.org/keywords/gynecology |
| keywords[3].score | 0.3322575092315674 |
| keywords[3].display_name | Gynecology |
| keywords[4].id | https://openalex.org/keywords/internal-medicine |
| keywords[4].score | 0.0712604820728302 |
| keywords[4].display_name | Internal medicine |
| language | pt |
| locations[0].id | doi:10.1016/j.htct.2024.09.014 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S2898598332 |
| locations[0].source.issn | 2531-1379, 2531-1387 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2531-1379 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Hematology Transfusion and Cell Therapy |
| locations[0].source.host_organization | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_name | Elsevier BV |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320990 |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Hematology, Transfusion and Cell Therapy |
| locations[0].landing_page_url | https://doi.org/10.1016/j.htct.2024.09.014 |
| locations[1].id | pmh:oai:doaj.org/article:1f78a6c96a0e473abffacd2a62dc28f5 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306401280 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[1].source.host_organization | |
| locations[1].source.host_organization_name | |
| locations[1].source.host_organization_lineage | |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | article |
| locations[1].license_id | |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S8- (2024) |
| locations[1].landing_page_url | https://doaj.org/article/1f78a6c96a0e473abffacd2a62dc28f5 |
| indexed_in | crossref, doaj |
| authorships[0].author.id | https://openalex.org/A5068034581 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | DB Menin |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | DB Menin |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5040132614 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | MF Barros |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | MF Barros |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5114334114 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | RAT Takaes |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | RAT Takaes |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5093082327 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | GE Dresch |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | GE Dresch |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5053082184 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | IP Roman |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | IP Roman |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5030310636 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Les P. Miranda |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | LT Miranda |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5114334115 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | MC Capelin |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | MC Capelin |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5078811132 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | RA Sri Martini |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | RA Martini |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5108698477 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | V. C. Araujo |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | VS Araújo |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5109888321 |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | MAF Chaves |
| authorships[9].author_position | last |
| authorships[9].raw_author_name | MAF Chaves |
| authorships[9].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1016/j.htct.2024.09.014 |
| open_access.oa_status | diamond |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | DESAFIOS NO MANEJO DE ANEMIA FERROPRIVA GRAVE EM PACIENTES IDOSOS: RELATO DE CASO |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10554 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9580000042915344 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2716 |
| primary_topic.subfield.display_name | Genetics |
| primary_topic.display_name | Hemoglobinopathies and Related Disorders |
| related_works | https://openalex.org/W4391375266, https://openalex.org/W2899084033, https://openalex.org/W2748952813, https://openalex.org/W3031052312, https://openalex.org/W4389568370, https://openalex.org/W3032375762, https://openalex.org/W1995515455, https://openalex.org/W2080531066, https://openalex.org/W3108674512, https://openalex.org/W1506200166 |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1016/j.htct.2024.09.014 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2898598332 |
| best_oa_location.source.issn | 2531-1379, 2531-1387 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2531-1379 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Hematology Transfusion and Cell Therapy |
| best_oa_location.source.host_organization | https://openalex.org/P4310320990 |
| best_oa_location.source.host_organization_name | Elsevier BV |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| best_oa_location.license | |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Hematology, Transfusion and Cell Therapy |
| best_oa_location.landing_page_url | https://doi.org/10.1016/j.htct.2024.09.014 |
| primary_location.id | doi:10.1016/j.htct.2024.09.014 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S2898598332 |
| primary_location.source.issn | 2531-1379, 2531-1387 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2531-1379 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Hematology Transfusion and Cell Therapy |
| primary_location.source.host_organization | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_name | Elsevier BV |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Hematology, Transfusion and Cell Therapy |
| primary_location.landing_page_url | https://doi.org/10.1016/j.htct.2024.09.014 |
| publication_date | 2024-10-01 |
| publication_year | 2024 |
| referenced_works_count | 0 |
| abstract_inverted_index.7 | 303 |
| abstract_inverted_index.< | 302 |
| abstract_inverted_index.A | 1, 88, 249 |
| abstract_inverted_index.O | 36 |
| abstract_inverted_index.a | 10, 124, 127, 138, 141, 151, 160, 174, 218, 278, 285, 299, 309, 313, 322, 324, 329, 334, 348, 357, 361, 367, 400 |
| abstract_inverted_index.e | 30, 56, 102, 120, 133, 157, 168, 204, 241, 281, 338, 365, 399 |
| abstract_inverted_index.o | 42, 110, 193, 228, 289, 316, 354, 373, 406, 420 |
| abstract_inverted_index.12 | 259 |
| abstract_inverted_index.30 | 225 |
| abstract_inverted_index.31 | 105 |
| abstract_inverted_index.37 | 277 |
| abstract_inverted_index.61 | 78 |
| abstract_inverted_index.Ao | 147 |
| abstract_inverted_index.Em | 181 |
| abstract_inverted_index.ao | 206, 221 |
| abstract_inverted_index.as | 22 |
| abstract_inverted_index.da | 69, 112, 291, 384, 402 |
| abstract_inverted_index.de | 7, 44, 53, 62, 64, 72, 96, 116, 118, 131, 135, 162, 178, 187, 197, 202, 215, 230, 243, 245, 251, 258, 264, 276, 336, 363, 375, 393, 410 |
| abstract_inverted_index.do | 66, 149 |
| abstract_inverted_index.em | 28, 191, 208, 371 |
| abstract_inverted_index.na | 15, 200 |
| abstract_inverted_index.no | 92 |
| abstract_inverted_index.os | 274, 396 |
| abstract_inverted_index.um | 340 |
| abstract_inverted_index.é | 9, 40, 257 |
| abstract_inverted_index.170 | 279 |
| abstract_inverted_index.2CH | 132 |
| abstract_inverted_index.3,1 | 97 |
| abstract_inverted_index.4,5 | 100 |
| abstract_inverted_index.4,6 | 284 |
| abstract_inverted_index.5,3 | 145 |
| abstract_inverted_index.6,1 | 179 |
| abstract_inverted_index.7,1 | 232 |
| abstract_inverted_index.UBS | 201 |
| abstract_inverted_index.aos | 185, 262 |
| abstract_inverted_index.com | 25, 47, 159, 169, 176, 195, 356, 419 |
| abstract_inverted_index.deu | 90 |
| abstract_inverted_index.dos | 171, 271, 391 |
| abstract_inverted_index.nos | 381 |
| abstract_inverted_index.por | 60 |
| abstract_inverted_index.que | 331, 378, 405 |
| abstract_inverted_index.ser | 327 |
| abstract_inverted_index.uma | 45, 155, 411 |
| abstract_inverted_index.15,9 | 239 |
| abstract_inverted_index.16,0 | 236 |
| abstract_inverted_index.Essa | 18 |
| abstract_inverted_index.Para | 108 |
| abstract_inverted_index.caso | 43, 111, 407 |
| abstract_inverted_index.como | 295 |
| abstract_inverted_index.deve | 326 |
| abstract_inverted_index.duas | 209 |
| abstract_inverted_index.logo | 164 |
| abstract_inverted_index.mais | 13, 154, 188, 413 |
| abstract_inverted_index.meio | 61 |
| abstract_inverted_index.novo | 213 |
| abstract_inverted_index.não | 320, 388 |
| abstract_inverted_index.para | 144, 211, 255, 266, 282, 344, 415 |
| abstract_inverted_index.pela | 5, 51 |
| abstract_inverted_index.pois | 298 |
| abstract_inverted_index.qual | 325 |
| abstract_inverted_index.sexo | 76 |
| abstract_inverted_index.2010, | 84 |
| abstract_inverted_index.204,0 | 286 |
| abstract_inverted_index.364,0 | 247 |
| abstract_inverted_index.Após | 137 |
| abstract_inverted_index.ainda | 387 |
| abstract_inverted_index.anos, | 79 |
| abstract_inverted_index.após | 224, 352 |
| abstract_inverted_index.caso, | 376 |
| abstract_inverted_index.caso: | 73 |
| abstract_inverted_index.casos | 307 |
| abstract_inverted_index.causa | 330 |
| abstract_inverted_index.dados | 65 |
| abstract_inverted_index.desde | 83 |
| abstract_inverted_index.deste | 38 |
| abstract_inverted_index.dias, | 226 |
| abstract_inverted_index.enfim | 345 |
| abstract_inverted_index.está | 332 |
| abstract_inverted_index.ferro | 103, 198, 234, 246, 267, 364 |
| abstract_inverted_index.g/dL, | 98, 233, 304 |
| abstract_inverted_index.g/dL. | 146, 180, 260 |
| abstract_inverted_index.houve | 379 |
| abstract_inverted_index.idade | 401 |
| abstract_inverted_index.maior | 26 |
| abstract_inverted_index.mesma | 89, 128 |
| abstract_inverted_index.ng/mL | 101, 240 |
| abstract_inverted_index.obter | 416 |
| abstract_inverted_index.tendo | 227 |
| abstract_inverted_index.todas | 21 |
| abstract_inverted_index.ug/dL | 280 |
| abstract_inverted_index.valor | 177 |
| abstract_inverted_index.Anemia | 349 |
| abstract_inverted_index.Devido | 123 |
| abstract_inverted_index.Estudo | 58 |
| abstract_inverted_index.Quanto | 261 |
| abstract_inverted_index.Relato | 71 |
| abstract_inverted_index.anemia | 2, 48, 81, 119, 296 |
| abstract_inverted_index.atinge | 20 |
| abstract_inverted_index.baixa, | 126 |
| abstract_inverted_index.coleta | 63 |
| abstract_inverted_index.dentro | 270, 390 |
| abstract_inverted_index.devido | 184 |
| abstract_inverted_index.estão | 389 |
| abstract_inverted_index.exames | 115 |
| abstract_inverted_index.ferro, | 8, 163, 337 |
| abstract_inverted_index.ferro. | 54, 136, 216 |
| abstract_inverted_index.finais | 383 |
| abstract_inverted_index.grave, | 297 |
| abstract_inverted_index.manter | 192 |
| abstract_inverted_index.nesses | 306 |
| abstract_inverted_index.ng/dL. | 287 |
| abstract_inverted_index.normal | 254 |
| abstract_inverted_index.origem | 203 |
| abstract_inverted_index.perfil | 214 |
| abstract_inverted_index.porém | 319, 386 |
| abstract_inverted_index.quadro | 290 |
| abstract_inverted_index.relato | 374 |
| abstract_inverted_index.riscos | 186 |
| abstract_inverted_index.saúde | 16 |
| abstract_inverted_index.tratar | 346 |
| abstract_inverted_index.ug/dL, | 237 |
| abstract_inverted_index.ug/dL. | 106, 248 |
| abstract_inverted_index.voltou | 220 |
| abstract_inverted_index.E.F.S., | 75 |
| abstract_inverted_index.Levando | 370 |
| abstract_inverted_index.Porém, | 217 |
| abstract_inverted_index.ameniza | 315 |
| abstract_inverted_index.anemia, | 323 |
| abstract_inverted_index.atingir | 33 |
| abstract_inverted_index.avaliar | 212 |
| abstract_inverted_index.causada | 4, 50 |
| abstract_inverted_index.classes | 23 |
| abstract_inverted_index.corrige | 321 |
| abstract_inverted_index.deve-se | 359 |
| abstract_inverted_index.doença | 19 |
| abstract_inverted_index.entrada | 91 |
| abstract_inverted_index.fazendo | 85 |
| abstract_inverted_index.graves. | 35 |
| abstract_inverted_index.levando | 333 |
| abstract_inverted_index.melhora | 170, 380 |
| abstract_inverted_index.nota-se | 404 |
| abstract_inverted_index.níveis | 272 |
| abstract_inverted_index.pode-se | 293 |
| abstract_inverted_index.podendo | 32 |
| abstract_inverted_index.recebeu | 129, 153 |
| abstract_inverted_index.relatar | 41 |
| abstract_inverted_index.relatos | 397 |
| abstract_inverted_index.semanas | 210 |
| abstract_inverted_index.sérico | 104, 235 |
| abstract_inverted_index.valores | 263, 275, 392 |
| abstract_inverted_index.Paciente | 74 |
| abstract_inverted_index.aumentou | 143 |
| abstract_inverted_index.clínico | 408 |
| abstract_inverted_index.crônica | 49, 82 |
| abstract_inverted_index.decorrer | 148 |
| abstract_inverted_index.estável | 166 |
| abstract_inverted_index.hospital | 93 |
| abstract_inverted_index.iniciais | 398 |
| abstract_inverted_index.mulheres | 256 |
| abstract_inverted_index.objetivo | 37 |
| abstract_inverted_index.optou-se | 190 |
| abstract_inverted_index.paciente | 46, 152, 219, 355 |
| abstract_inverted_index.problema | 317 |
| abstract_inverted_index.rastreio | 117 |
| abstract_inverted_index.retornar | 205 |
| abstract_inverted_index.sociais, | 24 |
| abstract_inverted_index.sérico, | 268 |
| abstract_inverted_index.trabalho | 39 |
| abstract_inverted_index.Avaliando | 395 |
| abstract_inverted_index.Materiais | 55 |
| abstract_inverted_index.Portanto, | 351 |
| abstract_inverted_index.apresenta | 80 |
| abstract_inverted_index.carência | 11 |
| abstract_inverted_index.continuar | 360 |
| abstract_inverted_index.crianças | 29 |
| abstract_inverted_index.crônico, | 343 |
| abstract_inverted_index.feminino, | 77 |
| abstract_inverted_index.ferritina | 99, 238, 283 |
| abstract_inverted_index.indica-se | 308 |
| abstract_inverted_index.ligação | 244 |
| abstract_inverted_index.mulheres, | 31 |
| abstract_inverted_index.métodos: | 57 |
| abstract_inverted_index.necessita | 409 |
| abstract_inverted_index.paciente, | 113, 292, 385, 403 |
| abstract_inverted_index.paciente. | 70 |
| abstract_inverted_index.positivos | 418 |
| abstract_inverted_index.possível | 341 |
| abstract_inverted_index.pública. | 17 |
| abstract_inverted_index.realizado | 59 |
| abstract_inverted_index.resultado | 229 |
| abstract_inverted_index.sintomas, | 172 |
| abstract_inverted_index.acompanhar | 366 |
| abstract_inverted_index.capacidade | 242 |
| abstract_inverted_index.criteriosa | 414 |
| abstract_inverted_index.endovenoso | 199 |
| abstract_inverted_index.evidência | 27 |
| abstract_inverted_index.ferropriva | 3 |
| abstract_inverted_index.hospitalar | 68 |
| abstract_inverted_index.investigar | 109, 339 |
| abstract_inverted_index.percebe-se | 377 |
| abstract_inverted_index.permaneceu | 158 |
| abstract_inverted_index.prevalente | 14 |
| abstract_inverted_index.resultados | 382, 417 |
| abstract_inverted_index.tratamento | 150, 194 |
| abstract_inverted_index.Conclusão: | 369 |
| abstract_inverted_index.Entretanto, | 312 |
| abstract_inverted_index.Ferropriva. | 350 |
| abstract_inverted_index.aceitáveis | 273 |
| abstract_inverted_index.avaliação | 121, 182 |
| abstract_inverted_index.considerada | 253 |
| abstract_inverted_index.estabelecer | 353 |
| abstract_inverted_index.evolução. | 368 |
| abstract_inverted_index.frequentes. | 87 |
| abstract_inverted_index.hemoglobina | 95, 125, 142, 175, 231, 252, 300 |
| abstract_inverted_index.investigada | 328 |
| abstract_inverted_index.nutricional | 12 |
| abstract_inverted_index.prontuário | 67 |
| abstract_inverted_index.referência | 265 |
| abstract_inverted_index.reposição | 134, 161, 196, 362 |
| abstract_inverted_index.sangramento | 342 |
| abstract_inverted_index.sanguínea, | 140 |
| abstract_inverted_index.sanguínea. | 311 |
| abstract_inverted_index.transfusão | 130, 139, 156, 310, 314 |
| abstract_inverted_index.tratamento. | 421 |
| abstract_inverted_index.Considerando | 288 |
| abstract_inverted_index.ambulatorial | 223 |
| abstract_inverted_index.ambulatório | 207 |
| abstract_inverted_index.apresenta-se | 301 |
| abstract_inverted_index.apresentando | 94, 173 |
| abstract_inverted_index.considera-se | 269 |
| abstract_inverted_index.deficiência | 6, 52, 335 |
| abstract_inverted_index.solicitou-se | 114 |
| abstract_inverted_index.transfusão, | 358 |
| abstract_inverted_index.transfusões | 86 |
| abstract_inverted_index.apresentou-se | 165 |
| abstract_inverted_index.implicações | 34 |
| abstract_inverted_index.referências. | 394 |
| abstract_inverted_index.transfusões, | 189 |
| abstract_inverted_index.acompanhamento | 222 |
| abstract_inverted_index.classificá-lo | 294 |
| abstract_inverted_index.concentração | 250 |
| abstract_inverted_index.consideração | 372 |
| abstract_inverted_index.hematológica, | 183 |
| abstract_inverted_index.hematológica. | 122 |
| abstract_inverted_index.investigação | 412 |
| abstract_inverted_index.definitivamente | 347 |
| abstract_inverted_index.consequentemente | 305 |
| abstract_inverted_index.temporariamente, | 318 |
| abstract_inverted_index.hemodinamicamente | 167 |
| abstract_inverted_index.Introdução/Objetivo: | 0 |
| abstract_inverted_index.Resultados/Discussão: | 107 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 10 |
| citation_normalized_percentile.value | 0.35451382 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |